Eric Topol warns that lifting a ban on injected drugs without safety or efficacy data to allow compounding would be unprecedented and a major regulatory red line.
it crosses a new red line
unprecedented.
without data for safety or efficacy
so they can be compounded
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare